Godrej Agrovet Q2 FY27: Revenue up 17% to ₹2,995 cr, PAT up 22% to ₹103 cr
Q2 FY27 revenue up 17% to ₹2,995 cr and PAT up 22% to ₹103 cr, but EBITDA flat at ₹222 cr and margin down 120 bps to 7.4%.
By ScoutQuest · · 1 min read
- Q2 FY27 revenue
- revenue up 17% to ₹2,995 cr
- Q2 FY27 PAT
- PAT up 22% to ₹103 cr
- Q2 FY27 EBITDA margin
- EBITDA flat at ₹222 cr and margin down 120 bps to 7.4%
- Period
- Q2 FY27 and H1 FY27
- Positioning
- A six-segment agri portfolio: Animal Nutrition at 46% of Q2 FY27 revenue, Oil Palm 27%, Creamline Dairy 14%, Crop Care 7%, Godrej Foods 7% and Astec Lifesciences 2%.
📉 Q2 FY27 consolidated revenue rose 17% to ₹2,995 cr from ₹2,564 cr, but EBITDA was flat at ₹222 cr and EBITDA margin fell 120 bps to 7.4% from 8.6%; profit after tax rose 22% to ₹103 cr from ₹84 cr, with PAT margin up 10 bps at 3.4%.
📉 For the half year, revenue rose 13% to ₹5,847 cr, while EBITDA as reported fell 5% to ₹476 cr and PAT fell 1% to ₹231 cr, with EBITDA margin down 160 bps to 8.1%. Segments dragged: Crop Care's Q2 FY27 segment result fell 23% on a 1,070 bps margin slide to 12.6%, and Oil Palm's margin fell 420 bps to 18.2% even as its revenue rose 28%.
📌 The company presents itself as a six-segment agri franchise and says premiumisation is the common thread: Animal Nutrition's premium portfolio grew ~20% vs LY, Creamline Dairy lifted value-added salience to ~49% in H1 FY27 and Godrej Foods raised B2C salience to ~38% from ~27% LY.
🏭 Management states it will keep funding long-term priorities: Ashitaka traction (~6X H1 sales vs LY), a CDMO portfolio and dedicated BD team at Astec, Oil Palm acreage and the newly commissioned Khammam complex and CPKO refinery, and new product development that made up ~24% of Godrej Foods B2C H1 revenue. It flags Crop Care's H2 outlook as muted given El Niño and continued volatility.
Also from Godrej Agrovet
Godrej Agrovet posts audio recording of November 6, 2026 investor and analyst conference call
6 Nov 2026
Q2 revenue up 17%, PAT up 22%, EBITDA flat; H1 revenue up 13%
6 Nov 2026
Board approves unaudited Q2 and H1 results; auditors' limited review opinion unmodified
6 Nov 2026
More numbers
- Revenue, Q2 FY272,995 (₹ cr)
- EBITDA, Q2 FY27222 (₹ cr)
- Profit after tax, Q2 FY27103 (₹ cr)
- EBITDA margin %, Q2 FY277.4%
- Revenue, H1 FY275,847 (₹ cr)
- EBITDA as reported, H1 FY27476 (₹ cr)
- Profit after tax as reported, H1 FY27231 (₹ cr)
- Oil Palm segment revenue, Q2 FY27784 (₹ cr)
- Crop Care segment result, Q2 FY2725 (₹ cr)
- Godrej Foods revenue, Q2 FY27198 (₹ cr)
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.